Skip to main content

Table 1 Pathogen and patient characteristics

From: Multiresistant ST59-SCCmec IV-t437 clone with strong biofilm-forming capacity was identified predominantly in MRSA isolated from Chinese children

Characteristics

Total

MRSA

MSSA

P value

Patients

104

60

44

 

Patient characteristics

 Female sex, n (%)

41 (39.4)

28 (46.7)

13 (29.5)

0.1044

 Age (months), median (IQRa)

5.2 (49.6)

3.9 (57.5)

8.3 (49.4)

0.424

 Age distribution

   

0.7883

  ≤ 28 day

31 (29.8)

20 (33.3)

11 (25.0)

 

 29 day-3 years

46 (44.2)

25 (41.7)

21 (47.7)

 

 4–6 years

10 (9.6)

5 (8.3)

5 (11.4)

 

 7–15 years

17 (16.4)

10 (16.7)

7 (15.9)

 

Origin

   

1.000

 Community associated

57 (54.8)

33 (55.0)

24 (54.5)

 

 Hospital associated

47 (45.2)

27 (45.0)

20 (45.5)

 

Disease

   

0.0031

 Skin and soft tissue infection

37 (35.58)

28 (46.7)

9 (20.5)

 

 Pneumonia

44 (42.3)

24 (40.0)

20 (45.5)

 

 Bloodstream infection

21 (20.2)

6 (10.0)

15 (34.1)

 

 Bone and joint infection

2 (1.9)

2 (3.3)

0

 

Laboratory examination

 White cell count-Median (IQR) (109/L)

13.7 (9.88)

13.9 (8.7)

13.3 (12.4)

0.5834

 Neutrophil count-Median (IQR) (109/L)

7.9 (10.74)

8.7 (10.4)

7.2 (11.9)

0.7365

 Neutrophils percentage-Median (IQR)

61.6 (33.3)

62.1 (30.0)

60.9 (36.8)

0.7107

 C-reactive protein-Median (IQR) (mg/L)

18.5 (51.5)

14.0 (66.0)

24.0 (50.0)

0.8506

 Co-infectionb

34.0 (32.7)

18.0 (30.0)

16 (36.4)

0.5308

Hospitalization

 Hospital days-median (IQR)

13 (11.0)

12 (10)

13 (10.8)

0.9056

 Intensive care unit (ICU) admission

26 (25.0)

12 (20.0)

14 (31.8)

0.1789

MLST

   

<0.0001

 5

5 (4.8)

0

5 (11.4)

 

 6

5 (4.8)

1 (1.7)

4 (9.1)

 

 7

4 (3.8)

0

4 (9.1)

 

 22

11 (10.6)

2 (3.3)

9 (20.5)

 

 25

4 (3.8)

0

5 (11.4)

 

 59

49 (47.1)

46 (76.7)

3 (6.8)

 

 188

4 (3.8)

0

4 (9.1)

 

 398

5 (4.8)

0

5 (11.4)

 

 Othersc

17 (16.3)

11 (18.3)

6 (13.6)

 

spa type

   

<0.0001

 t002

4 (3.8)

0

4 (9.1)

 

 t189

4 (3.8)

0

4 (9.1)

 

 t309

12 (11.5)

3 (5.0)

9 (20.5)

 

 t437

41 (39.4)

39 (65.0)

2 (4.5)

 

 t441

4 (3.8)

4 (6.7)

0

 

 t701

4 (3.8)

0

4 (9.1)

 

 Othersd

35 (33.7)

14 (23.3)

30 (68.2)

 

SCCmec type (only for MRSA)

   

/

 IV

51 (85.0)

51 (85.0)

/

 

 V

6 (10.0)

6 (10.0)

/

 

 NTe

3 (5.0)

3 (5.0)

/

 
  1. aIQR, interquartile range
  2. bIncluding bacteria (Pertussis, Acinetobacter baumanii, Klebsiella pneumoniae, Pseudomonas aeruginosa, Escherichia coli, Mycobacterium Tuberculosis, Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae, Enterobacter cloacae), fungus (Candida albicans, Candida krusei), virus (Respiratory syncytial virus, Influenza A virus, Adenovirus, Cytomegalovirus) and Mycoplasma pneumoniae
  3. cThe other MLSTs were ST1 (1 isolate), ST30 (1 isolate), ST97 (1 isolate), ST121 (1 isolate), ST338 (2 isolates), ST896 (1 isolate), ST1224 (1 isolate), ST1821 (1 isolate) in the MRSA group, and ST1 (1 isolate), ST15 (3 isolates), ST121 (1 isolate), ST950 (1 isolate) in the MSSA group
  4. dThe other spa types were t021 (1 isolate), t114 (3 isolates), t163 (1 isolate), t172 (2 isolates), t267 (1 isolate), t1751 (1 isolate), t3515 (1 isolate), t3590 (1 isolate), t4549 (1 isolate), t8860 (1 isolate), t12946 (1 isolate) in the MRSA group, and t034 (2 isolates), t078 (2 isolates), t084 (3 isolates), t091 (2 isolates), t127 (1 isolate), t163 (1 isolate), t167 (1 isolate), t310 (1 isolate), t571 (3 isolates), t660 (1 isolate), t796 (1 isolate), t1062 (1 isolate), t1818 (1 isolate), t2092 (1 isolate) in the MSSA group
  5. eNontypable
Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us